company
ANI Pharmaceuticals, Inc.
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_recall · drug_recall2026-07-01ANI Pharmaceuticals, Inc. — Class III recall: hydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 473 mL (1 Pint), Rx on…
- fda_recall · drug_recall2026-05-27ANI Pharmaceuticals, Inc. — Class II recall: Estradiol Gel, 0.1%, 0.25 mg, 0.25 g per packet, 30 packets per carton, Rx only,…
Frequently asked questions
- How many FDA warning letters has ANI Pharmaceuticals, Inc. received?
- Argus HQ has not recorded an FDA warning letter for ANI Pharmaceuticals, Inc. in our current dataset.
- What FDA recalls has ANI Pharmaceuticals, Inc. issued?
- Argus HQ has recorded 2 FDA recalls tied to ANI Pharmaceuticals, Inc..
- Is ANI Pharmaceuticals, Inc. FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 2 recalls, and 0 approval records for ANI Pharmaceuticals, Inc.. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.

